Metraipolis › archive › dc_0a76d343d587

Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node-Targeting and Augments mRNA Vaccine Efficacy — Europe PMC PMID:42801710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42801710
DOI
10.1002/advs.77923
License (as archived)
solo-consultazione
Archived
2026-10-07T20:46:34.385Z
SHA-256 of the archived text
17708b8af644832372551bc1d13042915094b76ed839c0b41348fecb6418dff1
Stable URL of this page
https://metraipolis.com/documento/dc_0a76d343d587

How to cite

Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node-Targeting and Augments mRNA Vaccine Efficacy — Europe PMC PMID:42801710 — Europe PMC (en), https://europepmc.org/article/MED/42801710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0a76d343d587 (Metraipolis archive dc_0a76d343d587, sha256 17708b8af644832372551bc1d13042915094b76ed839c0b41348fecb6418dff1)
BibTeX
@misc{dc0a76d343d587,
  title = {Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node-Targeting and Augments mRNA Vaccine Efficacy — Europe PMC PMID:42801710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42801710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0a76d343d587; sha256 17708b8af644832372551bc1d13042915094b76ed839c0b41348fecb6418dff1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42801710. Agents can read the archived copy with the MCP tool read_document.